Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - API & CRAMS
  4. /SMS Pharmaceuticals Ltd
MomentumDeep Value

SMS Pharmaceuticals Ltd: Stock Analysis & Fundamentals

Updated this week

SMS Pharmaceuticals Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 34.8. ROE: 14.3%. This stock is not currently in the Nifty 500 momentum outperformers list.

SMS Pharmaceuticals Ltd Key Facts

What's Happening

💪Debt reduced 11% YoY — balance sheet strengthening
👔Promoter buying — stake up 3.4% this quarter

Key Risks

1. Geopolitical
MEDIUM
2. Commodity
MEDIUM

Key Numbers

Current Price
₹378
Dividend Yield
0.11%
Market Cap
3.5K Cr
Valuation
N/A

What Are the Key Risks for SMS Pharmaceuticals Ltd?

Earnings deceleration risks from management commentary

Geopolitical

MEDIUM

Trigger: Chinese competition

Monitor: geopolitical

Commodity

MEDIUM

Trigger: raw material volatility

Monitor: commodity

What Is SMS Pharmaceuticals Ltd's Management Saying?

Key quotes from recent conference calls

“faces headwinds from raw material volatility and Chinese competition [Risk (geopolitical): MEDIUM]”
“faces headwinds from raw material volatility [Risk (commodity): MEDIUM]”

The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 30, 2026.

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Laurus Labs Ltd
Average • 11w streak
+34.1%
Anthem Biosciences Ltd
Average • 10w streak
+10.3%
Gland Pharma Ltd
Average • 5w streak
+27.7%
Acutaas Chemicals Ltd
Average • 12w streak
+23.0%
Sai Life Sciences Ltd
Average • 11w streak
+13.0%
← Back to Pharma - API & CRAMSDashboard

Frequently Asked Questions: SMS Pharmaceuticals Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were SMS Pharmaceuticals Ltd's latest quarterly results?

SMS Pharmaceuticals Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: +65.0%
  • Revenue Growth YoY: -4.0%
  • Operating Margin: 17.0%

What is SMS Pharmaceuticals Ltd's current PE ratio?

SMS Pharmaceuticals Ltd's current PE ratio is 34.8x.

  • Current PE: 34.8x
  • Market Cap: 3.5K Cr
  • Dividend Yield: 0.11%

What is SMS Pharmaceuticals Ltd's price-to-book ratio?

SMS Pharmaceuticals Ltd's price-to-book ratio is 4.5x.

  • Price-to-Book (P/B): 4.5x
  • Book Value per Share: ₹84
  • Current Price: ₹378

Is SMS Pharmaceuticals Ltd a fundamentally strong company?

SMS Pharmaceuticals Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 13.0%

Is SMS Pharmaceuticals Ltd debt free?

SMS Pharmaceuticals Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹365 Cr

What is SMS Pharmaceuticals Ltd's return on equity (ROE) and ROCE?

SMS Pharmaceuticals Ltd's return ratios over recent years

  • FY2024: ROCE 12.0%
  • FY2025: ROCE 13.0%
  • FY2026: ROCE 13.0%

Is SMS Pharmaceuticals Ltd's cash flow positive?

SMS Pharmaceuticals Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹59 Cr
  • Free Cash Flow (FCF): ₹-72 Cr
  • CFO/PAT Ratio: 58% (adequate)

What is SMS Pharmaceuticals Ltd's dividend yield?

SMS Pharmaceuticals Ltd's current dividend yield is 0.11%.

  • Dividend Yield: 0.11%
  • Current Price: ₹378

Who holds SMS Pharmaceuticals Ltd shares — promoters, FII, DII?

SMS Pharmaceuticals Ltd's shareholding pattern (Mar 2026)

  • Promoters: 68.1%
  • FII (Foreign): 0.3%
  • DII (Domestic): 3.0%
  • Public: 28.6%

Is promoter holding increasing or decreasing in SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 68.1% (Mar 2026)
  • Previous Quarter: 68.1% (Dec 2025)
  • Change: 0.00% (stable)

Is SMS Pharmaceuticals Ltd a new momentum entry or an established outperformer?

SMS Pharmaceuticals Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

What are the key risks in SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd has 2 key risks worth monitoring

  • [MEDIUM] Geopolitical — Chinese competition
  • [MEDIUM] Commodity — raw material volatility

What did SMS Pharmaceuticals Ltd's management say in the latest earnings call?

In Sep 2025, SMS Pharmaceuticals Ltd's management highlighted

  • "faces headwinds from raw material volatility and Chinese competition [Risk (geopolitical): MEDIUM]"
  • "faces headwinds from raw material volatility [Risk (commodity): MEDIUM]"

Is SMS Pharmaceuticals Ltd worth studying for long term investment?

Based on quantitative research signals, here is why SMS Pharmaceuticals Ltd may be worth studying

  • Cash flow is positive — CFO ₹59 Cr

What is the investment thesis for SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd investment thesis summary:

Risk Factors (Bear Case)

  • Key risk: Geopolitical

What is the future outlook for SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd's forward outlook based on current data signals

  • Key Risk: Geopolitical

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.